I-, MN- and Pr1/Pr2-activity of human erythrocyte glycoprotein fractions obtained by ficin treatment.
D000818:Animals; D000941:Antigens; D001789:Blood Group Antigens; D002845:Chromatography; D010450:Endopeptidases / Q000494:pharmacology*; D004912:Erythrocytes / Q000032:analysis / Q000276:immunology*; D006020:Glycopeptides / Q000032:analysis; D006023:Glycoproteins / Q000097:blood*; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D008259:Macroglobulins; D009438:Neuraminic Acids / Q000097:blood; D011817:Rabbits; D008258:Waldenstrom Macroglobulinemia / Q000276:immunology
D000941:Antigens; D001789:Blood Group Antigens; D006020:Glycopeptides; D006023:Glycoproteins; D007106:Immune Sera; D008259:Macroglobulins; D009438:Neuraminic Acids; D010450:Endopeptidases